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Abstracts / Biol Blood Marrow Transplant 21 (2015) S171eS184 S181Methods: This was a retrospective study that evaluated the
prevalence of and risk factors associated with metabolic
syndrome early post-HCT in 785 human subjects. As data
was collected retrospectively, it required substitution for
certain metabolic syndrome parameters. Thus, we evaluated
metabolic characteristics using available objective data
referred to as modiﬁed metabolic syndrome (MMS).
Results: We demonstrated that the incidence of MMS was
34% pre-HCT, 48% at day 80 post-HCT, and 40% at one year
post-HCT. MMS at day 80 post-HCT was predictive of having
MMS at one year post-HCT. Hypertriglyceridemia was the
predominant qualifying criteria for MMS, present in 91-93%
of patients. Age (>50) and TBI-based conditioning regimen
were signiﬁcantly associated with developing MMS at day 80
post-HCT (p¼0.0006 and p¼0.005, respectively). Both TBI
and age remain highly signiﬁcant in multivariate analysis
(p¼0.0009 for TBI and p¼0.0001 for age) at day 80 post-HCT.
TBI was also predictive of MMS at 1 year post-HCT (p¼0.01).
Conclusion: Although we substitute a number of the meta-
bolic syndrome factors based on data availability, we believe
that the substituted factors used in this study are still clini-
cally relevant as risk factors for coronary heart disease. These
results support the need for nutrition and lifestyle interven-
tion in order to prevent and treat metabolic abnormalities
among patients who survive the acute transplant period.Figure 1. Provider population.
Figure 2. Barriers to oncofertility education practice experienced by hema-
tology oncology physicians and nurses.233
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Background: Infertility frequently occurs in long-term sur-
vivors of hematopoietic stem cell transplant (HSCT). By the
timepatients are referred forHSCT, theyhaveoftenundergone
cancer treatments that cause infertility. The burden of early
education fallson thehematologyoncology teamthat cares for
the patient upon initial cancer diagnosis. Comprehensive
oncofertility education should include two areas: the risk of
cancer treatment on future fertility and fertility preservation
(FP) options. This study sought to characterize the education
practice and attitudes of hematology oncology physicians and
nurses towardsoncofertilityeducation inpatientswhomaybe
HSCTeligible and to determine patients’ interest in education.
Methods: A multidisciplinary team developed 3 surveys to
evaluate patients, nurses, and physicians using published
literature and unique questions targeting our population.
The University of Virginia’s Institutional Review Board (IRB)
authorized the surveys as IRB exempt. Practicing hematology
oncology nurses and physicians were eligible. Potential HSCT
eligible patients diagnosed with lymphoma, leukemia, or
myeloma in the last 2 years and were either women ages 18-
45 or men ages 18-60 at time of diagnosis were eligible.
Results: A total of 23 hematologic cancer patients ages 23-49
completed the survey as well as 43 providers (Figure 1).
Education on the risk of cancer treatment on future fertility
was received by 52% of patients, and only 26% of patients
received FP options. 81% of women and 31% of men wereinterested in discussing their fertility, learning about FP
options, or a fertility referral and counseling service. Of those
interested, 67% received education on the risk of cancer
treatment to fertility and 42% received FP education. Of
interested patients who received education, 63% were
satisﬁed with risk of cancer treatment education, and 80%
were satisﬁed with FP education. Of the surveyed providers,
75% of nurses and 33% of physicians did not feel comfortable
discussing FP options with patients and 89% of nurses and
86% of physicians felt they needed more information on FP
options. Physicians indicated patients’ illness and nurses
indicated their own knowledge of FP as the greatest barriers
to education (Figure 2).
Conclusions: The majority of hematology oncology patient
participants did not receive comprehensive oncofertility edu-
cation. Unfortunately, many patients interested in education
did not receive it. Providers need oncofertility education to
improve their ability to address topics. HSCT programs should
collaborate with local fertility specialists to educate primary
Abstracts / Biol Blood Marrow Transplant 21 (2015) S171eS184S182oncologists and potential HSCT patients, thereby increasing
access to FP treatment and ensuring all patients of child-
bearing potential receive education at time of cancer diagnosis.
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Background: Hematopoietic stem cell transplant (HSCT) sur-
vivors and their partners frequently struggle with infertility
post HSCT, which can decrease quality of life (QOL). With an
increasing number of HSCT survivors, a systematic pre-trans-
plant and survivorship care plan that includes oncofertility is
eagerly needed. A comprehensive guideline on oncofertility
education and referral does not exist for HSCT patients.
Therefore, our HSCT program developed an Oncofertility Ed-
ucation and Referral Program (OERP) to empower HSCT phy-
sicians, nurses, and patients with knowledge of fertility
preservation (FP) and family planning options. The strategy
and tools of our OERP implementation can assist transplant
groups at other institutions in initiating similar programs.
Methods: A multidisciplinary team identiﬁed barriers that
providersexperience indeliveringoncofertilityeducation, and
dealing with programmatic barriers for referrals to repro-
ductive specialists. The American Society of Clinical Oncology
(ASCO) and National Comprehensive Cancer Network (NCCN)
guidelines on oncofertility education were used to develop
program-speciﬁc guidelines and educational material for
providers and patients. A referral network was built through
collaboration with local reproductive medicine specialists.
Results: OERP implementation occurred over a 12-month
period fromJuly2013 to July2014 (Figure1).Weput into service
a standard operating procedure (SOP) on FP Education and
Referral that incorporated ASCO and NCCN guidelines as
well as a referral algorithmwith contact information. Biannual
in-service oncofertility education sessions were provided to
HSCT physicians, nurses, and support staff. Provider educationFigure 1. Flow chart depicting strategy andpackets that include national guidelines, referral contacts,
and support services were made available on the shared drive
for anytime access. Patient education packets that contain a
one-page fact sheet, local reproductive medicine clinic
information, FP ﬁnancial assistance, and support services
were also made available on shared drive. Oncofertility
discussions were incorporated into programmatic patient care
committee meetings and patient intake education sessions to
ensure oncofertility education is delivered from the beginning
of patient care. A computer-based learning module was
created for continuing education and is undergoing
institutional review for implementation.
Conclusions: We created a comprehensive OERP for HSCT
providers and patients. Success of the OERPwill bemeasured
annually through reproductive specialist referral metrics and
surveys given periodically to patients and providers. In an
effort to improve HSCT survivors’ QOL, programs should
implement an OERP to ensure patients make informed de-
cisions concerning the future of their reproductive health
before undergoing HSCT.235
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Introduction: Long-term stable mixed chimerism (MC) is
rare after allogeneic hematopoietic stem cell transplantation
(HSCT). MC is deﬁned as 5-95% residual recipient hemato-
poietic cells beyond one-year post-HSCT. The mechanisms
directing hematopoietic recovery to MC in some patients and
to full donor chimerism (DC) in others are poorly understood.
Methods: We compared patients with DC and long-term
stable MC for a median of 9.5 years post-HSCT. Both the
clinical situation and the immune system (functional and
phenotypic properties) were investigated by questionnaires,
western blot, multiplex bead-based immunoassay, ELISA and
ﬂow cytometry. Blood samples were drawn at 2 weeks and
>5 years post-HSCT. Additionally, lineage-speciﬁc chimerism
status in the MC patients was determined. The results were
analyzed by the Mann-Whitney U test, Fisher’s exact test and
Spearman’s rank correlation coefﬁcient.processes of OERP implementation.
